Teva divesting $1 billion in assets to clear Allergan deal
The assets that Teva is divesting span the United States, Europe and the Middle East, and will be sold in a series of processes that are expected to be completed in early 2016, the sources said. Teva expects to complete its US divestitures by January, and has received offers from a number of generic pharmaceutical companies, one of the sources added.
This asset sale is in addition to the following news
Teva needs to sell a range of overlapping generic drugs in order to gain antitrust approval for its $40.5 billion purchase of Allergan Plc’s generics business. The portfolio contains about 35 generic products for the US market, including oral solids, capsules, soft gels and hormones, one of the people said.
http://www.livemint.com/Companies/BBp8FW8b90YXMiZ9DT4XAK/Glenmark-Sun-Pharma-Cipla-said-to-weigh-bid-for-Teva-portf.html
So if I understood it correctly, there is a drug portfolio as well as assets up for sale.
Torrent is in a sweet spot to benefit from any good opportunity that comes along.
| Subscribe To Our Free Newsletter |
